HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Slotting Fee Replacement By Post-Marketing Methods Suggested To FTC

This article was originally published in The Tan Sheet

Executive Summary

Alternative mechanisms to slotting fees designed to ensure retailers that unsuccessful products will not remain on shelves should be considered for the grocery industry, panel members asserted at a Federal Trade Commission public meeting on slotting fees in Washington, D.C. May 31-June 1.

You may also be interested in...



FTC Slotting Fee Investigation To Receive $900,000 In Funding

The Federal Trade Commission is slated to receive nearly $1 mil. in funding under the agency's FY 2001 budget, earmarked for studying the practice of retail slotting fees.

Manufacturer-Initiated Fees To Retailers May Require FTC Scrutiny - Attorney

Manufacturer/supplier-initiated payments to retailers related to shelf space may require Federal Trade Commission analysis to determine if the conduct is anticompetitive, a Chicago antitrust attorney told commission reps during a public meeting on slotting fees in Washington, D.C. May 31-June 1.

FTC "Slotting Fee" Practices Investigation Requested By Senate Cmte.

The Senate Committee on Small Business is sending letters to the Federal Trade Commission and General Accounting Office the week of Sept. 20 asking the organizations to take a close look at the practice of charging "slotting fees" for shelf space in retail outlets. The committee held a hearing on the subject Sept. 14.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133174

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel